These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5741541)

  • 1. [Findings on the use of low molecular weight dextran in arteriopathic patients].
    Mirenda P
    Minerva Cardioangiol; 1968 Jan; 16(1):48-57. PubMed ID: 5741541
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fluidifying action of 3(methyl-oxyethylamino)-2 oxypropyl-theophylline nicotinate (Vedrin)].
    Molino N; Belluardo C; Catalano S
    Minerva Cardioangiol; 1966 Feb; 14(2):85-8. PubMed ID: 5931706
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of low-molecular dextran on plasma cholesterol level in patients with arteriosclerosis].
    Himmel A; Tkaczewski W; Walasek L
    Pol Tyg Lek; 1970 Jan; 25(2):43-5. PubMed ID: 5415359
    [No Abstract]   [Full Text] [Related]  

  • 4. [Dextran 70 perfusion in treatment in arteriosclerosis obliterans].
    Brassai Z; Ferencz L; Vánesa G; Kovalszky P
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1977; 29(3):231-60. PubMed ID: 18777
    [No Abstract]   [Full Text] [Related]  

  • 5. [Considerations on the use of dextran of low molecular weight in the treatment of peripheral arteriopathy].
    Serra GC; Verlato R
    Acta Anaesthesiol; 1965; 16():Suppl 5:87-95. PubMed ID: 5899665
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hemorrhagic diathesis in a patient with obliterative arteriosclerosis during treatment with low-molecular dextran].
    Szmidt M; Rozniecki J; Religa H
    Pol Tyg Lek; 1972 Oct; 27(40):1566-8. PubMed ID: 5081828
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of fibrinolysis activation on the peripheral blood circulation in occlusive vascular diseases].
    Bielawiec M; Lukjan H
    Med Monatsschr; 1971 Jul; 25(7):312-4. PubMed ID: 5563915
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy of peripheral obliterating arteriopathies with intra-arterial perfusions of dextran of low molecular weight and vasodilator agents].
    Buccellato C; Di Lorenzo GD
    Minerva Chir; 1967 Jun; 22(11):692-5. PubMed ID: 6050666
    [No Abstract]   [Full Text] [Related]  

  • 9. [Thrombolytic agents and substances with "minor fibrinolytic" effect].
    Verstraete M; Amery A
    Rev Atheroscler (Paris); 1968; 10(2):21-7. PubMed ID: 5759946
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of eledoisin on the rheogram in arteriosclerosis obliterans].
    Szám I; Kusztos D; Csapó G
    Arzneimittelforschung; 1966 Dec; 16(12):1671-3. PubMed ID: 6014806
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of dextran of low molecular weight in the prevention of secondary thrombosis in direct operations on the arteries. Preventive note].
    Seghezzi R; Taborelli R; Maurizio A
    Minerva Chir; 1967 Feb; 22(4):170-2. PubMed ID: 6050195
    [No Abstract]   [Full Text] [Related]  

  • 12. Dextran 40 and dextran 70. A review.
    Atik M
    Arch Surg; 1967 May; 94(5):664-72. PubMed ID: 6025903
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical tests using pyridinol carbamate on the arterial circulation and blood coagulation in patients with arteriosclerosis obliterans].
    De Soldati L; Castro CM; Grilli H; Reussi J
    Prensa Med Argent; 1969 May; 56(12):546-53. PubMed ID: 5343928
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on drug controlled blood distribution as a conservative therapeutic principle in arteriosclerosis obliterans].
    Mörl H; Preuss EG; Bartusch M; Schneider W
    Z Kreislaufforsch; 1972 Feb; 61(2):144-52. PubMed ID: 5026177
    [No Abstract]   [Full Text] [Related]  

  • 15. [Short-term heparin therapy in obliterating arteriopathies of the lower limbs].
    Arrigo F; Coglitore S; Giannetto M; Bramanti O; Barbera C; Consolo F
    Boll Soc Ital Cardiol; 1977; 22(3):273-82. PubMed ID: 617274
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of bencyclane in obliterative arterial diseases].
    Kusztos D
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1419+. PubMed ID: 5536658
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of low molecular weight dextran in peripheral arterial disease.
    Hardy DA; Klippel AP
    Am Surg; 1969 Jul; 35(7):468-70. PubMed ID: 5785907
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of low molecular dextran on lower-leg blood flow in normal subjects and patients with peripheral arterial circulation disorders].
    Gottstein U; Sedlmeyer I; Schöttler M; Gülk V
    Dtsch Med Wochenschr; 1970 Sep; 95(39):1955-9. PubMed ID: 5458695
    [No Abstract]   [Full Text] [Related]  

  • 19. Observations on the clinical use of dextran for the treatment of vascular disease.
    Lee WH; Cooper N; Russel HE; Ballenger J; Murner ES
    Acta Chir Scand Suppl; 1968; 387():61-8. PubMed ID: 5256246
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of a single infusion of low-molecular dextran in patients with chronic obliterative arterial diseases].
    Chrzanowski W
    Pol Tyg Lek; 1969 Jul; 24(27):1057-9. PubMed ID: 4896578
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.